At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
2017/0296508 |
Applications of Substituent Benzyloxy Group Containing Ether Compounds for
Preparing Antitumor Drugs Disclosed are applications of substituent benzyloxy group containing ether compounds represented by general formula I for preparing antitumor drugs. ... |
2017/0296507 |
SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid... |
2017/0296506 |
METHODS FOR ADMINISTRATION AND METHODS FOR TREATING CARDIOVASCULAR
DISEASES WITH RESINIFERATOXIN The present application provides methods for treating cardiovascular conditions. The methods can include administering a Transient Receptor Potential Vanilloid... |
2017/0296505 |
LONG-CHAIN CARBOXYCHROMANOLS AND ANALOGS FOR USE AS ANTI-INFLAMMATORY
AGENTS Long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or... |
2017/0296504 |
ANTIVIRAL EFFECTS OF NARASIN IN SWINE FEED The present invention relates to a composition for ameliorating viral infections in nursery pigs. The composition contains the polyether ionophore narasin, and... |
2017/0296502 |
METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS Embodiments provided herein include methods, compositions, and uses of aromatic alcohols to increase the potency of antifungal agents. |
2017/0296501 |
ADMINISTRATION OF BUTYRATE, BETA-HYDROXYBUTYRATE, AND RELATED COMPOUNDS IN
HUMANS In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight... |
2017/0296500 |
Uses of Chlorogenic Acid in the Preparation of Medicaments for Treatment
of Psoriasis The present invention provides uses of chlorogenic acid in the preparation of medicaments for treatment of psoriasis. Chlorogenic acid, a small molecular... |
2017/0296499 |
COMBINATIONAL COMPOSITIONS AND METHODS OF USE THEREOF Disclosed are compositions and methods for the treatment of a disease or disorder comprising i) at least one fatty acid, and ii) at least one cholesterol... |
2017/0296498 |
Rapid Relief of Motor Fluctuations in Parkinson's Disease The present invention provides methods for treating OFF episodes in a Parkinson's Disease patient comprising administering levodopa to the pulmonary system of... |
2017/0296497 |
TREATMENT AND DIAGNOSIS OF COLON CANCER The present invention discloses novel agents and methods for diagnosis and treatment of colon cancer. Also disclosed are related arrays, kits, and screening... |
2017/0296496 |
Ibuprofen Nanoparticle Carriers Encapsulated with Hermatic Surfactant
Films The present invention provides a water continuous dispersion of nanoparticles including Ibuprofen; one or more high HLB surfactants; one or more low HLB... |
2017/0296495 |
LIQUID DOSAGE FORMS OF SODIUM NAPROXEN Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the... |
2017/0296494 |
Biomarkers for Risk Assessment, Diagnosis and Target Microbiome and
Intestinal Homeostasis for Prevention and... Methods of selecting a subject for treatment of amyotrophic lateral sclerosis (ALS) and methods of treatment for subjects having ALS or at risk of developing... |
2017/0296493 |
Sotalol Compositions and Uses of the Same The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability.... |
2017/0296492 |
COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE
THEREOF Pharmaceutical compositions for reducing frequency of urination are disclosed. The pharmaceutical compositions comprise one or more prostaglandin pathway... |
2017/0296491 |
PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA AMIDE AND USES THEREOF The present invention discloses various aqueous pharmaceutical compositions comprising a levodopa amide compound, or a salt thereof, which are stable for at... |
2017/0296490 |
USE OF LIGNIN-DERIVED ALDEHYDES AS ANTIFUNGAL AGENTS Described herein is a method and corresponding composition of matter for inhibiting the growth of fungi and oomycetes. The method includes contacting fungi or... |
2017/0296489 |
Cooling Adjunct For Medications To Treat Disorders In The Nasal Cavity The present discovery pertains generally to the field of therapeutic compounds. More specifically the present discovery pertains to certain ... |
2017/0296488 |
RESVERATROL EXTRACTION FROM GNETUM AFRICANUM The invention relates to extracts and compositions from Gentum africanum. It also concerns plant extracts enriched in resveratrol and methods for obtaining the... |
2017/0296487 |
REDUCING REFLUX WHILE SLEEPING BY STIMULATING SALIVA WITH ADHERING TROCHES A method of reducing reflux from a stomach toward a mouth while sleeping in a person in need thereof by providing to the person an adhering, bilayer troche,... |
2017/0296486 |
Composition for the Transdermal Delivery of Fentanyl A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery... |
2017/0296485 |
Topical Film-Forming Spray A polymeric bio-adhesive film forming topical spray formulation providing a modified, pulsatile (e.g., biphasic) release of the active agent(s) once the... |
2017/0296484 |
Topical Film-Forming Spray A polymeric bio-adhesive film forming topical spray formulation providing a modified, pulsatile (e.g., biphasic) release of the active agent(s) once the... |
2017/0296483 |
METHODS AND BIOCOMPATIBLE COMPOSITIONS TO ACHIEVE SUSTAINED DRUG RELEASE
IN THE EYE A nanostructured biocompatible wafer for placement in the conjunctival cul-de-sac. The wafer contains a tissue-reactive mucoadhesive polymer and a mesh formed... |
2017/0296482 |
SUBLINGUAL AND BUCCAL FILM COMPOSITIONS The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The... |
2017/0296481 |
COMPOSITIONS AND METHODS FOR BILE ACID PARTICLES Therapeutic compositions are disclosed which contain a therapeutic agent and a bile acid or bile acid conjugate. The compositions can be absorbed via... |
2017/0296480 |
NANOPARTICLES FOR CONTROLLED LYSIS OF BLOOD CLOTS Fibrinolytic nanoparticles including a polymeric core having a surface that is functionalized with a cationic amphiphilic compound, and a fibrinolytic agent... |
2017/0296479 |
CORE-SHELL PARTICLES AND METHOD OF MANUFACTURING THE SAME Provided are core-shell particles which are kept stable in a solvent such as water for a long period. Each core-shell particle includes a core which contains a... |
2017/0296478 |
FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN THE GUT The invention relates to a formulation for the delayed and controlled delivery of an adsorbent into the lower intestine of mammals. The formulation includes a... |
2017/0296477 |
Methods of Treatment of Attention Deficit Hyperactivity Disorder Therapeutic compositions and methods for treatment of attention deficit disorder (ADD) or attention deficit hyperactivity disorder (ADHD) include dosage forms... |
2017/0296476 |
MODIFIED RELEASE ABUSE DETERRENT DOSAGE FORMS The invention relates to a pharmaceutical dosage form for oral administration comprising a pharmacologically active compound; wherein a portion of said... |
2017/0296475 |
HYDROCORTISONE CONTROLLED RELEASE FORMULATION The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed... |
2017/0296474 |
METHOD OF MANUFACTURING ENTERIC SEAMLESS SOFT CAPSULE An object is to provide a method of manufacturing a seamless soft capsule that is enteric and excellent in formulation properties. An enteric seamless soft... |
2017/0296473 |
METHOD OF MAKING A SOFT GEL CAPSULE COMPRISING COQ-10 SOLUBILIZED IN A
MONOTERPENE The present invention is directed to compositions and methods of delivery of CoQ-10 solubilized in monoterpenes. Use of monoterpenes as dissolving agents,... |
2017/0296472 |
Tamper resistant dosage form with bimodal release profile The invention relates to a pharmaceutical dosage form comprising (i) at least one formed segment (S.sub.1), which contains a first pharmacologically active... |
2017/0296471 |
UNIQUE HIGH SPEED TABLET DRILLING LASER SYSTEM An apparatus for high speed laser drilling of tablets, particularly controlled-release tablets is disclosed. The apparatus comprises of a rotary disk (118)... |
2017/0296470 |
TWO SPEED MONOLOTHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS The present document describes a monolithic tablet dosage form for delivery of an active ingredient at two different release rates comprising a carboxyl... |
2017/0296469 |
LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM The present invention is related to a lipid composition contained in and/or containing a carrier comprising at least a first lipid component, at least a first... |
2017/0296468 |
IMPROVED SUGAR-DEPLETED FRUIT OR VEGETABLE JUICE AND JUICE-RETAINING FRUIT
OR VEGETABLE DERIVED MATTER, METHODS... The present invention provides a sugar-depleted fruit or vegetable juice product, wherein said juice product is a fruit or vegetable juice or juice-retaining... |
2017/0296467 |
CHEWABLE GELLED EMULSIONS An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising... |
2017/0296466 |
Injectable Non-Aqueous Compositions and Methods of Treating Vascular
Disease An injectable non-aqueous composition and a method of treating a vascular disease, the non-aqueous composition including: chitosan having a particle size of no... |
2017/0296465 |
MICRONEEDLE ARRAY To provide a microneedle array which includes a sheet and needles, improves transfer of a medicament into the blood, and is capable of achieving high drug... |
2017/0296464 |
LOW FREQUENCY GLATIRAMER ACETATE THERAPY A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a... |
2017/0296463 |
DEEP TOPICAL SYSTEMIC NITRIC OXIDE THERAPY APPARATUS AND METHOD A topical mixture that produces nitric oxide and a method for using the topical mixture to increase the vasodilation of a bloodstream via transdermal... |
2017/0296462 |
COMPOSITIONS FOR IMPROVING THE APPEARANCE OF AGING SKIN A cosmetic skin care composition for improving the appearance of aging skin. The composition is topically applied to a target area of skin where treatment is... |
2017/0296461 |
METHOD OF IMPROVING THE APPEARANCE OF PERIORBITAL DYSCHROMIA A method of improving the appearance of periorbital dyschromia by identifying a target portion of skin in the periorbital region of a person that exhibits... |
2017/0296460 |
METHOD OF IMPROVING THE APPEARANCE OF PERIORBITAL DYSCHROMIA A method of improving the appearance of periorbital dyschromia by identifying a target portion of skin in the periorbital region of a person that exhibits... |
2017/0296459 |
METHOD OF IMPROVING THE APPEARANCE OF PERIORBITAL DYSCHROMIA A method of improving the appearance of periorbital dyschromia by identifying a target portion of skin in the periorbital region of a person that exhibits... |
2017/0296458 |
COSMETIC COMPOSITION A cosmetic composition for improving the appearance of Type II and/or Type III periorbital dyschromia. The composition includes an effective amount of an... |